You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyclin-dependent Kinase 9

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cyclin-dependent Kinase Inhibitor 2A on Labor-related Signals

Not yet recruiting
  • Preterm Labor
    • (no location specified)
    May 9, 2023

    Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder

    Recruiting
    • Cyclin-Dependent Kinase-Like 5 Deficiency Disorder
    • No intervention; observational
    • Norcross, Georgia
      Center for Rare Neurological Diseases
    Oct 20, 2022

    Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

    Recruiting
    • Breast Cancer
    • CT scans
    • DEXA scan
    • Bronx, New York
      Montefiore Medical Center
    Jan 6, 2023

    Neurofibromatosis 1 Trial run by the National Cancer Institute (NCI) (Abemaciclib)

    Recruiting
    • Neurofibromatosis 1
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Cancer Trial in Boston (CYC065)

    Active, not recruiting
    • Cancer
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Apr 22, 2022

    Skin Health and Quality of Life in Patients Receiving

    Not yet recruiting
    • Lung Cancer
    • +7 more
    • EQ-5D-5L questionnaire
    • +2 more
    • Roma, Italy
      Roberto Iacovelli
    May 17, 2023

    Chondrosarcoma, Osteosarcoma, Soft Tissue Sarcoma Trial in United States (Abemaciclib)

    Recruiting
    • Chondrosarcoma
    • +2 more
    • Jacksonville, Florida
    • +3 more
    Apr 4, 2022

    Personalised Disease Monitoring in Metastatic Breast Cancer

    Recruiting
    • Breast Cancer Metastatic
    • Estrogen Receptor-positive Breast Cancer
      • Gothenburg, Sweden
      • +6 more
      Dec 7, 2022

      Metastatic Breast Cancer Trial in Spain (Pembrolizumab, Paclitaxel)

      Active, not recruiting
      • Metastatic Breast Cancer
      • Hospitalet de Llobregat, Barcelona, Spain
      • +6 more
      Jan 23, 2023

      Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

      Not yet recruiting
      • Extensive-stage Small-cell Lung Cancer
      • (no location specified)
      May 22, 2023

      CDKL5 Disorder Trial (Ganaxolone)

      Available
      • CDKL5 Disorder
      • (no location specified)
      Apr 1, 2022

      Advanced Malignant Solid Tumor, Metastatic Malignant Solid Tumor, Unresectable Solid Tumor Trial in United States (CDK Inhibitor

      Active, not recruiting
      • Advanced Malignant Solid Neoplasm
      • +2 more
      • CDK Inhibitor AT7519
      • +3 more
      • Washington, District of Columbia
      • +5 more
      Oct 18, 2022

      Triple Negative Breast Tumors Trial in Poland (Palbociclib, Paclitaxel, Carboplatin)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • Wrocław, Dolnośląskie, Poland
      • +5 more
      Oct 4, 2021

      Aggressive B-Cell Non-Hodgkin's Lymphoma, Aggressive B-Cell NHL, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Trial

      Not yet recruiting
      • Aggressive B-Cell Non-Hodgkin's Lymphoma
      • +4 more
      • (no location specified)
      Dec 16, 2022

      Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer Trial in Miami (AI+CDK4/6i, SERD+CDK4/6i, mTOR inhibitor +

      Not yet recruiting
      • Breast Cancer
      • +3 more
      • Miami, Florida
        University of Miami
      Apr 12, 2023

      Advanced Breast Cancer, Treatment-Refractory Solid Tumors, Retinoblastoma Deficiency Trial in Providence (Palbociclib Oral

      Not yet recruiting
      • Advanced Breast Cancer
      • +6 more
      • Providence, Rhode Island
        Lifespan Cancer Institute
      Feb 1, 2023

      Ewing Sarcoma, Myxoid/Round Cell Liposarcoma, Synovial Sarcoma Trial in United States (PRT2527)

      Recruiting
      • Ewing Sarcoma
      • +7 more
      • Denver, Colorado
      • +5 more
      Jun 9, 2022

      15q Duplication Syndrome, CDKL5 Deficiency Disease Trial in United States (Soticlestat)

      Completed
      Has Results
      • 15q Duplication Syndrome
      • CDKL5 Deficiency Disease
      • Los Angeles, California
      • +7 more
      May 24, 2022

      Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

      Not yet recruiting
      • Metastatic Breast Cancer
      • +4 more
      • CDK 4/6 inhibitors
      • Endocrine therapy
      • Helsinki, Finland
      • +11 more
      Sep 19, 2023

      Breast Cancer, Breast Cancer - Female, Breast Cancer - Male Trial in Tampa (Tamoxifen, Ribociclib, Goserelin)

      Completed
      Has Results
      • Breast Cancer
      • +2 more
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Jan 13, 2022

      CDKL5 Deficiency Disorder Trial (Ganaxolone, Placebo)

      Not yet recruiting
      • CDKL5 Deficiency Disorder
      • (no location specified)
      Feb 18, 2022

      Advanced Breast Cancer Trial in China (Palbociclib, Letrozole)

      Active, not recruiting
      Has Results
      • Advanced Breast Cancer
      • Beijing, Beijing, China
      • +6 more
      Jun 23, 2022

      Adult Solid Tumor, Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum Trial in Philadelphia (PD-0332991)

      Completed
      Has Results
      • Adult Solid Tumor
      • +38 more
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of The University of Pennsylvania
      Feb 18, 2021

      Solid Tumors Trial (ARTS-021, CDK 4/6 inhibitor, Fulvestrant 50 MG/ML Prefilled Syringe)

      Not yet recruiting
      • Solid Tumors
      • (no location specified)
      May 17, 2023

      Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma Trial in Los Angeles

      Recruiting
      • Recurrent Endometrial Carcinoma
      • +3 more
      • Los Angeles, California
        UCLA / Jonsson Comprehensive Cancer Center
      Oct 28, 2021